KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Royalty Pharma (RPRX) Shares Outstanding (Diluted Average) (2020 - 2025)

Royalty Pharma (RPRX) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $564.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) fell 4.99% to $564.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $564.5 million through Dec 2025, down 4.99% year-over-year, with the annual reading at $564.5 million for FY2025, 4.99% down from the prior year.
  • Shares Outstanding (Diluted Average) hit $564.5 million in Q4 2025 for Royalty Pharma, up from $559.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $607.3 million in Q1 2023 to a low of $414.8 million in Q4 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $578.3 million across 5 years, with a median of $599.3 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 71.52% in 2021 and later decreased 5.59% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $414.8 million in 2021, then increased by 5.59% to $438.0 million in 2022, then soared by 37.66% to $602.9 million in 2023, then decreased by 1.46% to $594.1 million in 2024, then dropped by 4.99% to $564.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for RPRX at $564.5 million in Q4 2025, $559.6 million in Q3 2025, and $570.2 million in Q2 2025.